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Summary 
A polyelectrolyte synthesized from cis-1,4-polyisoprene, containing amino- 
sulfonate and carboxylate groups was shown to have an anticoagulant activity of 
about 1/30 compared with heparin. Because the substance prevents the coagula- 
tion of plasma in the presence of thrombin it is assumed that it acts as an anti- 
thrombin. 
Recently, the addition reaction of N-chlorosulfonyl isocyanate and 
cis-1,4-polyisoprene has been reported.' It was shown that the 
addition product upon treatment with alkali gave a water soluble 
polyelectrolyte (A) containing the following structural unit : 
I 
NH 
SOtNa ONa 
I \  
The aminosulfonate and carboxylate groups are also present in the 
tetrasaccharide unit of the anticoagulant heparin, for which the 
following structure has been suggested:2 
CH,OSO; COOH CH,OSOC COOH 
Ij?-Jio*oj@oqL 0- 
H NHSOC H OH H NHSOC H OSO; 
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In  seeking new thromboresistant polymeric materials we in- 
vestigated the activit!y of A as an anticoagulant. The present results 
indicate that A acts as an antithrombin, with an activity of about 
1/30 compared with heparin. 
MATERIALS AND METHODS 
The polyelectrolyte A was synthesized as described.' Citrated 
human and bovine plasma were stored a t  - 26°C before use. Human 
plasma had a concentration of about 1.8.10-2 M disodium citrate 
and 2.0.10-2 M glucose. Prior to use the pH of the plasma was 
adjusted to 7.35 (unless otherwise stated) with the aid of 0.15 M 
HCl or 0.15 M Na2C03. 
Recalcification times of plasma were measured in Pyrex tubes 
with an outer diameter of 1.0 cm at 37°C. Part of the experiments 
were followed in an optical way as described by Matthews et al.3 
For this purpose a Vitatron colorirneter, Model UC 200 S, was used, 
equipped with a special thermostated vessel holder for the test tubes. 
Further, a 2 mm thick heat filter was placed between the lamp and 
vessel holder. Recalcification was carried out with 0.3 M CaClz 
(pH 7.35) to a final concentration of 1.9.10-2 M to 3.5.10-2 M of 
added CaC12. Heparin, 152 E/mg, was purchased from Diosynth 
(Oss, Holland). Thrombin in 0.05 M phosphate buffer (pH 7.0), 250 
NIH units/ml, was obtained from Sigma. 
Stock solutions of 12 mg/ml for both heparin and A were used for 
all measurements. The pH of these solutions was adjusted to 7.35 
prior to use. 
RESULTS AND DISCUSSION 
The anticoagdant activity of A compared with heparin in human 
plasma, is shown in Table I. 
At concentrations up to about 0.4 mg A/ml plasma a real coagula- 
tion of the plasma took place after recalcification. In the case of 
0.4 mg A/ml plasma the coagulation started after approximately 
20 min and was completed in about 40 min. When the concentra- 
tion was 0.8 mg A/ml, only some precipitate was formed at  the inter- 
face of plasma and air after about 5 hr. When the experiment was 
continued longer than 8 hr a precipitate was also observed in the 
liquid. A similar behavior was found when heparin was present in 
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TABLE I 
Anticoagulant Activity of A Compared With Heparin8 
Concentration of Concentration of A Beginning of 
heparin in plasma in plasma coagulation or 
(mg/ml) (mg/ml) precipitation 
no anticoagulant 
0.04 
0.06 
0.4 
0.8 
1.2 
clotting completed 
within 5 min 
21-28 min 
5-8 hr 
>8 hr 
> 6  hr 
>8 hr 
Conditions: aliquots of 1.5 ml citrated human plasma, pH 7.35, were incu- 
Recalcification was carried bated with the anticoagulant during 5 min at 37°C. 
out to a final concentration of 3.5.10-2 M of added CaC12. 
a concentration of 0.04 mg/ml plasma. When the concentration of 
A was 1.2 mg/ml no clotting or precipitation occurred even after 8 
hr. From the experiments it follows that the activity of A in pre- 
venting clot formation is about 1/20 compared with heparin. 
In Table I1 data on some coagulation experiments with bovine 
plasma in the presence of A are listed, for different concentrations 
of added CaC12 and different pH values. At low Ca2+ concentrations 
the coagulation times of plasma in the presence of A were less than 
those at high Ca2f concentrations. The anticoagulant effect of A 
cannot be explained, however, by assuming a complex between A 
and Ca2+. For instance, in the case of 0.2 mg A/ml plasma and 
3.5.10-2 M CaClz only 2% of the Ca2+ can be complexed, when it is 
assumed that the whole polymer consists of those units shown in the 
preceding structure (based on a ratio 1 unit: 1 Ca2+). Furthermore, 
a conductometric titration of A and Ca2+ did not indicate any 
complex formation. The anticoagulant activity is also not caused 
by a “soap-eff ect” of the polyelectrolyte. Comparable amounts of 
sodium dodecylsulfate even enhanced the clotting of plasma. No 
significant differences in recalcification times were found for the 
experiments in which pH values of 7.37 and 7.98 were used. 
The coagulation of bovine plasma is prevented at much lower con- 
centrations of both the anticoagulants A and heparin compared to 
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TABLE I1 
Anticoagnlant Activity of A in Bovine Plasma at Different Concentrations of 
Added CaClz and Different pH Values* 
Concentration 
of heparin in Concentration 
plasma of A in plasma Concentration Beginning of 
(mg/ml) (mg/ml) of CaClp (10-2 M) pH coagulation 
no anticoagulant 
0.008 
0.04 
0.08 
0 . 2  
0.04 
0.04 
0.06 
0.08 
no anticoagulant 
0.002 
0.003 
3 .5  
3 .5  
3 .5  
3.5 
3 .5  
1.9 
1.9 
1.9 
1 . 9  
1 . 9  
1.9 
1 .9  
7.76 
7.76 
7.76 
7.76 
7.76 
7.37 
7.37 
7.98 
7.98 
7.98 
7.98 
7.98 
5 . 5  min 
7 min 
21-26 rnin 
70 min 
> 8  hr 
4 min 
6-9 rnin 
8 min 
12 min 
18-20 rnin 
<12.5 min 
11.5 rnin 
a Aliquots of 1.5 ml plasma were incubated with A or heparin during 5 min at 
37°C before recalcification. 
human plasma. Because more precipitate is formed in bovine plasma 
than in human plasma during freezing, larger amounts of denaturated 
clotting factors may be present in the precipitate of bovine plasma. 
A comparable polymer was synthesized, starting from 3,4-poly- 
isoprene and N-chlorosulfonyl isocyanate. From the IR spectrum 
of the addition product it was expected that the alkaline hydrolysis 
product should contain less NH-S03Na-groups. In agreement 
with this assumption, the anticoagulant activity of this compound 
was found to be 4 to 5 times lower compared to A. A similar polymer 
derived from poly(2,3-dimethylbutadiene), which probably contains 
even fewer NH-S03Na-groups, was found to be even less active. 
In Table I11 data from some experiments are given, in which 
thrombin, together with a small amount of CaC12, was added to 
bovine plasma that had been incubated with A or heparin. In the 
presence of 1.67 NIH units thrombin/ml plasma and 1.9.10-2 M 
Ca2+ the coagulation time of plasma without an anticoagulant was 
about 30 sec. In the presence of A or heparin the coagulation of 
the plasma is strongly delayed. The fact that A prevents the 
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TABLE I11 
Anticoagulant Activity of A in the Presence of Thrombin* 
Concentration of heparin Concentration of A Beginning of 
in plasma (mg/ml) in plasma (mg/ml) coagulation 
no anticoagulant 
0.08 
0.16 
0.002 
0.004 
0.008 
<30 sec 
9-11 min 
> 2 . 5  hr 
5 min 
19 rnin 
> 2 . 5  hr 
a Aliquots of 1.5 ml bovine plasma were incubated with A or heparin during 
Then 1.67 NIH units thrombin/ml plasma were added together 5 min a t  37°C. 
with a solution of CaC12 to a final concentration of 1.9.10-2 M of added CaC12. 
clotting of plasma in the presence of thrombin indicates that i t  acts 
as an antithrombin. Whether A also interferes in earlier stages of 
the blood coagulation process is not yet known. From the experi- 
ments, listed in Table 111, in which the course of the clotting was 
also considered, it followed that the antithrombin activity of A is 
1/20 to  1/40 compared with heparin. This order of magnitude is 
the same as the anticoagulant activity that can be derived from the 
Tables I and 11. 
Attempts will be made to synthesize an insoluble polymer derived 
from A. This can be done either by starting from a partly cross- 
linked cis-1,4-polyisoprene or by crosslinking the final product A. 
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